Cancer associated antibody compositions and methods of use
US12134655B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2020 |
| Grant date | Nov 5, 2024 |
| Priority date | — |
| Expiry date | Apr 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.